1 rocalcinosis in oxalate nephropathy, such as
primary hyperoxaluria.
2 epresents a potential therapeutic target for
primary hyperoxalurias.
3 lanine-glyoxylate aminotransferase (AGXT) in
primary hyperoxaluria 1 (PH1) patients.
4 Primary hyperoxaluria 1 (PH1; Online Mendelian Inheritan
5 is a potential drug target for treatment of
primary hyperoxaluria,
a genetic disorder where overprod
6 ar acidosis with deafness, Bartter syndrome,
primary hyperoxaluria and cystinuria, in patients attend
7 fined despite their clinical significance in
primary hyperoxaluria and idiopathic calcium oxalate nep
8 Primary hyperoxalurias are a devastating family of disea
9 Primary hyperoxalurias are genetic diseases defined by e
10 nding the molecular aspect and management of
primary hyperoxalurias as well as nephropathic cystinosi
11 ance of having a high index of suspicion for
primary hyperoxaluria in patients with chronic kidney di
12 Primary hyperoxaluria is a rare autosomal recessive meta
13 Primary hyperoxaluria (
PH) is a family of ultra-rare aut
14 Primary hyperoxaluria (
PH) is a metabolic defect that re
15 Primary hyperoxaluria (
PH) is a rare autosomal recessive
16 Primary hyperoxaluria (
PH) is an autosomal recessive dis
17 Primary hyperoxaluria (
PH) is an inherited disorder that
18 n is the hallmark of all genetic subtypes of
primary hyperoxaluria (
PH).
19 es like transthyretin amyloidosis (ATTR) and
primary hyperoxaluria (
PH).
20 Primary hyperoxalurias (
PH) 1-3 are genetic diseases def
21 Primary hyperoxalurias (
PH) are inborn errors of glyoxyl
22 sferase (AGT), the metabolic error in type 1
primary hyperoxaluria (
PH1).
23 the enzymatic defect responsible for type 1
primary hyperoxaluria (
PH1).
24 pentol treatment of a single individual with
primary hyperoxaluria reduced the urinary oxalate excret
25 New therapeutics being developed for
primary hyperoxalurias take advantage of biochemical kno
26 Primary Hyperoxaluria Type 1 (PH1) is a rare autosomal r
27 Primary hyperoxaluria type 1 (PH1) is a rare genetic dis
28 Primary hyperoxaluria type 1 (PH1) is an inborn error of
29 Primary hyperoxaluria type 1 (PH1) is an inborn error of
30 Primary hyperoxaluria type 1 (PH1) is caused by defects
31 Primary hyperoxaluria type 1 (PH1) is caused by the func
32 Primary hyperoxaluria type 1 (PH1), an inherited rare di
33 editary calcium oxalate kidney stone disease
primary hyperoxaluria type 1 (PH1).
34 ially lethal hereditary kidney stone disease
primary hyperoxaluria type 1 (PH1).
35 ccumulation of intracellular oxalate and the
primary hyperoxaluria type 1 (PH1).
36 Primary hyperoxaluria type 1 (PHT1) treatment is mainly
37 e present the case of a child diagnosed with
primary hyperoxaluria type 1 after kidney transplant who
38 Primary hyperoxaluria type 1 is a rare inherited disorde
39 ecreasing glycolate and glyoxylate levels in
primary hyperoxaluria type 1 patients who have the inabi
40 In a mouse model of
primary hyperoxaluria type 1, rectal administration of O
41 stigational RNA interference therapeutic for
primary hyperoxaluria type 1.
42 cy of this enzyme is the underlying cause of
primary hyperoxaluria type 2 (PH2) and leads to increase
43 Outcome data in
primary hyperoxaluria type 3 (PH3), described as a less
44 Primary hyperoxaluria type I (PH1) is a rare kidney dise
45 atment for end-stage renal disease caused by
primary hyperoxaluria type I (PH1).
46 phosphate (PLP)-dependent enzymes, including
primary hyperoxaluria type I (PH1).
47 Primary hyperoxaluria type I is a severe kidney stone di
48 f which results in the kidney stone disease,
primary hyperoxaluria type I, identifying mutations that
49 nine:glyoxylate aminotransferase, mutated in
primary hyperoxaluria type I.
50 Primary hyperoxaluria type II (PH2) is a rare monogenic
51 Primary hyperoxaluria type-1 (PH1) is an autosomal reces
52 haperones) may be effective for treatment of
primary hyperoxaluria,
we propose that the methods descr